1.12

4.27% -0.05

NeuroOne Medical Technologies Corp (NMTC)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

NeuroOne Medical Technologies Corp stock is currently priced at $1.12, with a 24-hour trading volume of 154.82K. It has seen a -4.27% decreased in the last 24 hours and a -8.20% declined in the past month. The chart indicates a potential bearish trend, as the stock is below the $1.21 pivot point. If it approaches the $1.08 support level, significant changes may occur.

Previous Close:

$1.17

Open:

$1.16

24h Volume:

154.82K

Market Cap:

$29.04M

Revenue:

$2.82M

Net Income/Loss:

$-13.47M

P/E Ratio:

-1.8361

EPS:

-0.61

Net Cash Flow:

$-13.61M

1W Performance:

-3.45%

1M Performance:

-8.20%

6M Performance:

+5.66%

1Y Performance:

-17.65%

1D Range:

$1.12

$1.17

52W Range:

$0.85

$2.00

NeuroOne Medical Technologies Corp Stock (NMTC) Company Profile

Name

NeuroOne Medical Technologies Corp

Sector

Healthcare (1217)

Industry

Medical Devices (160)

Phone

952 426 1383

Address

7599 Anagram Drive, Eden Prairie

Employee

Twitter

Next Earnings Date

2024-05-09

Latest SEC Filings

NMTC's Discussions on Twitter

NeuroOne Medical Technologies Corp Stock (NMTC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Mar-29-22	Downgrade	Craig Hallum	Buy → Hold

NeuroOne Medical Technologies Corp Stock (NMTC) Latest News

NeuroOne® Reports First Quarter Fiscal Year 2024 Financial Results and Provides Corporate Update

GlobeNewswire Inc.

NeuroOne® to Report First Quarter Fiscal Year 2024 Financial Results and Provide Corporate Update on February 13

GlobeNewswire Inc.

NeuroOne® Reports Fiscal Fourth Quarter and Full Fiscal Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire Inc.

NeuroOne Medical Technologies Corp Stock (NMTC) Financials Data

NeuroOne Medical Technologies Corp (NMTC) Revenue 2024

NMTC reported a revenue (TTM) of $2.82 million for the quarter ending December 31, 2023, a +1,017% rise year-over-year.

NeuroOne Medical Technologies Corp (NMTC) Net Income 2024

NMTC net income (TTM) was -$13.47 million for the quarter ending December 31, 2023, a -50.94% decrease year-over-year.

NeuroOne Medical Technologies Corp (NMTC) Cash Flow 2024

NMTC recorded a free cash flow (TTM) of -$13.61 million for the quarter ending December 31, 2023, a -59.08% decrease year-over-year.

NeuroOne Medical Technologies Corp (NMTC) Earnings per Share 2024

NMTC earnings per share (TTM) was -$0.68 for the quarter ending December 31, 2023, a -21.43% decline year-over-year.

NeuroOne Medical Technologies Corp Stock (NMTC) Insider Trading

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total
Christianson Mark	Business Development Director	Dec 26 '23	Sale	1.35	6,848	9,269	332,039
Christianson Mark	Business Development Director	Dec 22 '23	Sale	1.40	1,800	2,520	338,887
Volker Christopher	Chief Operating Officer	Dec 21 '23	Buy	1.40	75,000	105,000	75,000
Christianson Mark	Business Development Director	Dec 21 '23	Sale	1.40	9,907	13,870	340,687
McClurg Ronald W.	Chief Financial Officer	Sep 13 '23	Buy	0.98	50,900	50,025	130,400

NeuroOne Medical Technologies Corporation operates as a medical technology company. The company focuses on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectroencephalography (sEEG) recording, spinal cord stimulation, brain stimulation, and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries, and other related neurological disorders. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.